Success Stories: Attending Physician Who Obtained EB-1A Approval Thanks to Unique Petition Packet is Now Ready for IVP
Client’s Testimonial:
“Thanks.”
On March 12th, 2018, we received another EB-1A (Alien of Extraordinary Ability) approval for an Attending Physician in the Field of Biomedical Research (Approval Notice).
General Field: Biomedical Research
Position at the Time of Case Filing: Attending Physician
Country of Origin: China
State of Residence at the Time of Filing: Outside the US
Approval Notice Date: March 12th, 2018
Processing Time: 5 Months, 2 Days
Case Summary:
An attending physician based in China hired North America Immigration Law Group (WeGreened.com) to help him build and file an EB-2 NIW (National Interest Waiver) petition. Nearly 2 years later, he contacted us again to file an EB-1A (Alien of Extraordinary Ability) petition. After determining that his credentials had significantly improved, we confirmed that he qualified for EB1A, one of the toughest I-140 categories to obtain approval.
One of the first things we did was to help our client secure recommenders. Recommenders are important as they provide subjective evidence of the value of our client’s work to the US. We helped our client narrow down a list of candidates—all of whom are experts in the field of biomedical research—and advised him to ask them for recommendation letters. Six experts agreed to lend their support, one of whom stated the following in his letter: “[Client’s] work has proven he is at the pinnacle of oncology and hematology studies, and his findings have been and will continue to be essential to developing effective diagnosis and treatment strategies for leukemia moving forward.”
Besides these recommendation letters, our client’s unique EB1A petition dossier contained data on the 150 times his work was cited, the 30 scientific articles in his name, and the 31 times he had assessed the work of his peers at the time of filing. The petition packet also contained summaries of our client’s various projects on hematology/oncology.
Our team worked hard to convince the USCIS that our client’s research addresses some of our nation’s most pressing issues in understanding the mechanisms of cancer drug resistance. The approval of this case is largely thanks to our unprecedented insight into how USICS officers adjudicate cases. With over 10,000 success stories, there is no doubt that we have firsthand information of any changes the USCIS makes in processing petitions.
We congratulate our client for overcoming this major hurdle in the green card process, and we thank him for retaining us to help him with immigrant visa processing (IVP)*.
*One is only eligible to file an I-485 if he/she is in the U.S. If one is outside the U.S., one must undergo Immigrant Visa Processing (IVP).